Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 685-696 of 4,306
Drug study icon
CompletedNCT05227690

A study of 10 and 30 mg Doses of CVL-231 (Emraclidine) in people with Schizophrenia

This study is completed in the United States and in Bulgaria. It focuses on schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Bulgaria
Sponsor
AbbVie
Condition
Schizophrenia
Other study type icon
UnknownNCT05948111

Assessment of Schizophrenia Patients' Clinical Study Experiences

This summary needs review. Please check the official study record and contact the research team for details.

In San Francisco
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.Over 18 Years
Countries
United States
Sponsor
Power Life Sciences Inc.
Condition
Schizophrenia
Other study type icon
CompletedNCT05742893

Comparison of a Speech-Language Assessment Tool for Pragmatic and Discourse Skills in Schizophrenia Spectrum Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Nice
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.From 18 Years to 99 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Nice
Condition
Schizophrenia
Behavioral study icon
CompletedNCT04221269

Suicide prevention Intervention for Schizophrenia-Spectrum Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Providence
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, SuicidalityBehavioralOver 18 Years
Countries
United States
Sponsor
Butler Hospital
Condition
Schizophrenia, Suicidality
Behavioral study icon
CompletedNCT03757988

Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Chapel Hill
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Schizophrenia
Behavioral study icon
CompletedNCT04916626

The OPUS YOUNG study. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In Hellerup
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, DepressionBehavioralFrom 12 Years to 17 Years
Countries
Denmark
Sponsor
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Condition
Schizophrenia, Depression
Drug study icon
CompletedNCT01006551

Ziprasidone in Early Onset Schizophrenia Spectrum Disorders

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Medford
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 6 Years to 19 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Schizophrenia
Drug study icon
Not recruitingISRCTN49141214

The benefit of minocycline on negative symptoms in schizophrenia

This study is testing a medication approach for people with Specialty: Mental Health, Primary sub-specialty: Psychosis or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOther
Countries
United Kingdom
Sponsor
Manchester Mental Health And Social Care NHS Trust
Condition
Schizophrenia
Drug study icon
CompletedNCT04659161

KarXT for schizophrenia

This study is completed in the United States. It is testing KarXT for schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.